| Package | tewhatuora.nzhts |
| Type | CodeSystem |
| Id | Id |
| FHIR Version | R4 |
| Source | fhir-ig.digital.health.nz/nzhts/https://build.fhir.org/ig/daniel-thomson/nzhts/CodeSystem-canshare-unpublished-concepts.html |
| Url | http://canshare.co.nz/fhir/CodeSystem/snomed-unpublished |
| Version | 0.1.0 |
| Status | active |
| Date | 2024-11-11T02:01:44+00:00 |
| Name | Canshare_unpublished_concepts |
| Title | Concepts that are not yet formally published |
| Experimental | False |
| Authority | national |
| Content | complete |
No resources found
FHIR
{
"resourceType" : "CodeSystem",
"id" : "canshare-unpublished-concepts",
"meta" : {
"versionId" : "1",
"lastUpdated" : "2024-11-05T17:14:43.036+13:00"
},
"url" : "http://canshare.co.nz/fhir/CodeSystem/snomed-unpublished",
"identifier" : [
{
"system" : "http://canshare.co.nz/fhir/NamingSystem/codesystems",
"value" : "canshare-unpublished-concepts"
}
],
"version" : "0.1.0",
"name" : "Canshare_unpublished_concepts",
"title" : "Concepts that are not yet formally published",
"status" : "active",
"date" : "2024-11-11T02:01:44+00:00",
"publisher" : "Health New Zealand | Te Whatu Ora",
"contact" : [
{
"name" : "Health New Zealand | Te Whatu Ora",
"telecom" : [
{
"system" : "url",
"value" : "https://www.tewhatuora.govt.nz/"
}
]
}
],
"caseSensitive" : true,
"content" : "complete",
"concept" : [
{
"code" : "392611000210105",
"display" : "BR Metastatic - cARBOplatin [2 AUC] and gemcitabine"
},
{
"code" : "392601000210108",
"display" : "BR Metastatic - ribociclib"
},
{
"code" : "392591000210103",
"display" : "LEU - GMALL T-LBL 1/2004 HDMTX/ASP [55 years and under]"
},
{
"code" : "392581000210100",
"display" : "LEU - GMALL T-LBL 1/2004 Consolidation [55 years and under]"
},
{
"code" : "392571000210102",
"display" : "LEU - GMALL T-LBL 1/2004 Pre-phase and Induction [55 years and under]"
},
{
"code" : "392561000210108",
"display" : "LEU ALL precursor T-cell - GMALL T-LBL 1/2004 [55 years and under]"
},
{
"code" : "392551000210105",
"display" : "LEU - GMALL T-LBL 1/2004 triple prophylaxis"
},
{
"code" : "392541000210107",
"display" : "LEU - GMALL T-LBL 1/2004 CYCLO/ARAC"
},
{
"code" : "392531000210104",
"display" : "LEU - GMALL T-LBL 1/2004 VM26/ARAC"
},
{
"code" : "392521000210101",
"display" : "LEU - GMALL T-LBL 1/2004 Reinduction"
},
{
"code" : "392511000210106",
"display" : "LEU - GMALL T-LBL 1/2004 HDMTX/ASP [over 55 years]"
},
{
"code" : "392501000210109",
"display" : "LEU - GMALL T-LBL 1/2004 Consolidation I [over 55 years]"
},
{
"code" : "392491000210104",
"display" : "LEU - GMALL T-LBL 1/2004 Pre-phase and Induction [over 55 years]"
},
{
"code" : "392481000210101",
"display" : "LEU ALL precursor T-cell - GMALL T-LBL 1/2004 [over 55 years]"
},
{
"code" : "392471000210103",
"display" : "LEU - HyperCVAD with pegaspargase [under 40 years] Part B with Intrathecal CNS prophylaxis High Risk"
},
{
"code" : "392461000210109",
"display" : "LEU - HyperCVAD with pegaspargase [under 40 years] Part B with Intrathecal CNS prophylaxis Unknown Risk [default]"
},
{
"code" : "392451000210106",
"display" : "LEU - HyperCVAD with pegaspargase [under 40 years] Part A with Intrathecal CNS prophylaxis High Risk"
},
{
"code" : "392441000210108",
"display" : "LEU - HyperCVAD with pegaspargase [under 40 years] Part A with Intrathecal CNS prophylaxis Unknown Risk [default]"
},
{
"code" : "392431000210100",
"display" : "LEU ALL - HyperCVAD with pegaspargase Part A and B followed by POMP Maintenance [under 40 years]"
},
{
"code" : "392421000210102",
"display" : "LEU - UKALL14 with RITUximab [over 40 years] [not for transplant] Consolidation/delayed intensification [Cycle 3]"
},
{
"code" : "392411000210107",
"display" : "LEU - UKALL14 with RITUximab [over 40 years] [not for transplant] Intensification/CNS prophylaxis"
},
{
"code" : "392401000210105",
"display" : "LEU ALL precursor B-cell - UKALL14 with RITUximab [over 40 years] [not for transplant]"
},
{
"code" : "392391000210107",
"display" : "LEU - UKALL14 with RITUximab [not for transplant] Maintenance"
},
{
"code" : "392381000210105",
"display" : "LEU - UKALL14 with RITUximab [40 years and under] [not for transplant] Consolidation/delayed intensification [Cycle 3]"
},
{
"code" : "392371000210108",
"display" : "LEU - UKALL14 with RITUximab [40 years and under] [not for transplant] Intensification/CNS prophylaxis"
},
{
"code" : "392361000210102",
"display" : "LEU - UKALL14 with RITUximab [not for transplant] Phase 2 Induction"
},
{
"code" : "392351000210100",
"display" : "LEU ALL precursor B-cell - UKALL14 with RITUximab [40 years and under] [not for transplant]"
},
{
"code" : "392341000210103",
"display" : "LEU - HyperCVAD with RITUximab [60 years and under] Part B with Intrathecal CNS prophylaxis High Risk"
},
{
"code" : "392331000210106",
"display" : "LEU - HyperCVAD with RITUximab [60 years and under] Part B with Intrathecal CNS prophylaxis Unknown Risk [default]"
},
{
"code" : "392321000210109",
"display" : "LEU - HyperCVAD with RITUximab [60 years and under] Part A with Intrathecal CNS prophylaxis High Risk"
},
{
"code" : "392311000210104",
"display" : "LEU - HyperCVAD with RITUximab [60 years and under] Part A with Intrathecal CNS prophylaxis Unknown Risk [default]"
},
{
"code" : "392301000210101",
"display" : "LEU ALL precursor B-cell - HyperCVAD with RITUximab Part A and B followed by POMP Maintenance [60 years and under]"
},
{
"code" : "392291000210100",
"display" : "LEU - HyperCVAD with RITUximab [over 60 years] Part B with Intrathecal CNS prophylaxis High Risk"
},
{
"code" : "392281000210102",
"display" : "LEU - HyperCVAD Part B with RITUximab [over 60 years] Intrathecal CNS prophylaxis Unknown Risk [default]"
},
{
"code" : "391941000210106",
"display" : "LEU - HyperCVAD Part A with RITUximab [over 60 years] Intrathecal CNS prophylaxis High Risk"
},
{
"code" : "391931000210103",
"display" : "LEU - HyperCVAD Part A with RITUximab [over 60 years] Intrathecal CNS prophylaxis Unknown Risk [default]"
},
{
"code" : "391921000210100",
"display" : "LEU ALL precursor B-cell - HyperCVAD with RITUximab Part A and B followed by POMP Maintenance [over 60 years]"
},
{
"code" : "391911000210105",
"display" : "LEU - UKALL14 with RITUximab [40 years and under] [for transplant] Consolidation/delayed intensification [Cycle 3]"
},
{
"code" : "391901000210108",
"display" : "LEU - UKALL14 with RITUximab [40 years and under] Consolidation [Cycle 1 and 2]"
},
{
"code" : "391891000210107",
"display" : "LEU - UKALL14 with RITUximab [40 years and under] [for transplant] Intensification/CNS prophylaxis"
},
{
"code" : "391881000210105",
"display" : "LEU - UKALL14 with RITUximab [40 years and under] Phase 1 Induction"
},
{
"code" : "391871000210108",
"display" : "LEU ALL precursor B-cell - UKALL14 with RITUximab [40 years and under] [for transplant]"
},
{
"code" : "391861000210102",
"display" : "LEU - UKALL14 Consolidation/delayed intensification [Cycle 3] [40 years and under]"
},
{
"code" : "391851000210100",
"display" : "LEU - UKALL14 Consolidation [Cycle 1] [40 years and under]"
},
{
"code" : "391841000210103",
"display" : "LEU - UKALL14 Intensification/CNS prophylaxis [40 years and under]"
},
{
"code" : "391831000210106",
"display" : "LEU - UKALL14 Phase 1 Induction [40 years and under]"
},
{
"code" : "391821000210109",
"display" : "LEU ALL - UKALL14 [40 years and under]"
},
{
"code" : "391811000210104",
"display" : "LEU - UKALL14 with RITUximab Consolidation [Cycle 4]"
},
{
"code" : "391801000210101",
"display" : "LEU - UKALL14 with RITUximab [over 40 years] [for transplant] Consolidation/delayed intensification [Cycle 3]"
},
{
"code" : "391791000210100",
"display" : "LEU - UKALL14 with RITUximab [over 40 years] Consolidation [Cycle 1 and 2]"
},
{
"code" : "391781000210102",
"display" : "LEU - UKALL14 with RITUximab [over 40 years] [for transplant] Intensification/CNS prophylaxis"
},
{
"code" : "391771000210104",
"display" : "LEU - UKALL14 with RITUximab [for transplant] Phase 2 Induction"
},
{
"code" : "391761000210105",
"display" : "LEU - UKALL14 with RITUximab [over 40 years] Phase 1 Induction"
},
{
"code" : "391751000210107",
"display" : "LEU ALL precursor B-cell - UKALL14 with RITUximab [over 40 years] [for transplant]"
},
{
"code" : "391741000210109",
"display" : "LEU - AIDA consolidation 3 [over 70 years]"
},
{
"code" : "391731000210101",
"display" : "LEU - AIDA consolidation 2 [over 70 years]"
},
{
"code" : "391721000210103",
"display" : "LEU - AIDA consolidation 1 [over 70 years]"
},
{
"code" : "391711000210108",
"display" : "LEU - AIDA induction [over 70 years]"
},
{
"code" : "391701000210106",
"display" : "LEU APL - AIDA induction and consolidations 1, 2 and 3 [over 70 years]"
},
{
"code" : "391691000210106",
"display" : "LEU AML - DA+GO-1 [DAUNOrubicin, cytarabine and Mylotarg [gemtuzumab ozogamicin]] induction [de novo CD33+] [good or intermediate risk]"
},
{
"code" : "391681000210109",
"display" : "LEU - Pethema LPA2005 maintenance [70 years and under] [low risk]"
},
{
"code" : "391671000210107",
"display" : "LEU - Pethema LPA2005 consolidation 3 [70 years and under] [low risk]"
},
{
"code" : "391661000210101",
"display" : "LEU - Pethema LPA2005 consolidation 2 [70 years and under] [low risk]"
},
{
"code" : "391621000210108",
"display" : "LEU - Pethema LPA2005 consolidation 1 [70 years and under] [low risk]"
},
{
"code" : "391601000210100",
"display" : "LEU - Pethema LPA2005 induction [70 years and under] [low risk]"
},
{
"code" : "391591000210105",
"display" : "LEU APL - Pethema LPA2005 induction and consolidations 1, 2 and 3 followed by maintenance [70 years and under] [low risk]"
},
{
"code" : "391581000210108",
"display" : "LEU - Pethema LPA2005 maintenance [over 70 years] [low risk]"
},
{
"code" : "391571000210106",
"display" : "LEU - Pethema LPA2005 consolidation 3 [over 70 years] [low risk]"
},
{
"code" : "391561000210100",
"display" : "LEU - Pethema LPA2005 consolidation 2 [over 70 years] [low risk]"
},
{
"code" : "391551000210103",
"display" : "LEU - Pethema LPA2005 consolidation 1 [over 70 years] [low risk]"
},
{
"code" : "391541000210101",
"display" : "LEU - Pethema LPA2005 induction [over 70 years] [low risk]"
},
{
"code" : "391531000210109",
"display" : "LEU APL - Pethema LPA2005 induction and consolidations 1, 2 and 3 followed by maintenance [over 70 years] [low risk]"
},
{
"code" : "391521000210107",
"display" : "LEU - Pethema LPA2005 maintenance [over 70 years] [high risk]"
},
{
"code" : "391511000210102",
"display" : "LEU - Pethema LPA2005 consolidation 3 [over 70 years] [high risk]"
},
{
"code" : "391501000210104",
"display" : "LEU - Pethema LPA2005 consolidation 2 [over 70 years] [high risk]"
},
{
"code" : "391491000210109",
"display" : "LEU - Pethema LPA2005 consolidation 1 [over 70 years] [high risk]"
},
{
"code" : "391481000210107",
"display" : "LEU - Pethema LPA2005 induction [over 70 years] [high risk]"
},
{
"code" : "391471000210105",
"display" : "LEU APL - Pethema LPA2005 induction and consolidations 1, 2 and 3 followed by maintenance [over 70 years] [high risk]"
},
{
"code" : "391461000210104",
"display" : "GU GCT Seminoma Adjuvant - cARBOplatin [7 AUC]"
},
{
"code" : "391451000210102",
"display" : "GU URO Advanced - cISplatin and gemcitabine"
},
{
"code" : "391441000210100",
"display" : "GU URO Advanced - cISplatin [split dose] and gemcitabine"
},
{
"code" : "391431000210108",
"display" : "GU Upper Tract Urothelial Adjuvant - cISplatin [split dose] and gemcitabine"
},
{
"code" : "391421000210106",
"display" : "GU GCT Metastatic - TIP [PACLItaxel, IFOSFamide and cISplatin]"
},
{
"code" : "391411000210101",
"display" : "LEU - Pethema LPA2005 maintenance [over 70 years] [intermediate risk]"
},
{
"code" : "312741000210103",
"display" : "LEU - Pethema LPA2005 consolidation 3 [over 70 years] [intermediate risk]"
},
{
"code" : "312731000210106",
"display" : "LEU - Pethema LPA2005 consolidation 2 [over 70 years] [intermediate risk]"
},
{
"code" : "312721000210109",
"display" : "LEU - Pethema LPA2005 consolidation 1 [over 70 years] [intermediate risk]"
},
{
"code" : "312711000210104",
"display" : "LEU - Pethema LPA2005 induction [over 70 years] [intermediate risk]"
},
{
"code" : "312701000210101",
"display" : "LEU APL - Pethema LPA2005 induction and consolidations 1, 2 and 3 followed by maintenance [over 70 years] [intermediate risk]"
},
{
"code" : "312691000210101",
"display" : "LEU - Pethema LPA2005 maintenance [under 60 years] [high risk]"
},
{
"code" : "312681000210103",
"display" : "LEU - Pethema LPA2005 consolidation 3 [under 60 years] [high risk]"
},
{
"code" : "312671000210100",
"display" : "LEU - Pethema LPA2005 consolidation 2 [under 60 years] [high risk]"
},
{
"code" : "312661000210106",
"display" : "LEU - Pethema LPA2005 consolidation 1 [under 60 years] [high risk]"
},
{
"code" : "312651000210108",
"display" : "LEU - Pethema LPA2005 induction [under 60 years] [high risk]"
},
{
"code" : "312631000210102",
"display" : "LEU APL - Pethema LPA2005 induction and consolidations 1, 2 and 3 followed by maintenance [under 60 years] [high risk]"
},
{
"code" : "312621000210104",
"display" : "LEU - Pethema LPA2005 maintenance [60 to 70 years] [high risk]"
},
{
"code" : "312611000210109",
"display" : "LEU - Pethema LPA2005 consolidation 3 [60 to 70 years] [high risk]"
},
{
"code" : "312601000210107",
"display" : "LEU - Pethema LPA2005 consolidation 2 [60 to 70 years] [high risk]"
},
{
"code" : "312591000210102",
"display" : "LEU - Pethema LPA2005 consolidation 1 [60 to 70 years] [high risk]"
},
{
"code" : "312581000210104",
"display" : "LEU - Pethema LPA2005 induction [60 to 70 years] [high risk]"
},
{
"code" : "312571000210101",
"display" : "LEU APL - Pethema LPA2005 induction and consolidations 1, 2 and 3 followed by maintenance [60 to 70 years] [high risk]"
},
{
"code" : "312561000210107",
"display" : "LEU - UKALL14 Maintenance"
},
{
"code" : "312551000210109",
"display" : "LEU - UKALL14 Consolidation [Cycle 4]"
},
{
"code" : "312541000210106",
"display" : "LEU - UKALL14 Consolidation/delayed intensification [Cycle 3] [over 40 years]"
},
{
"code" : "312531000210103",
"display" : "LEU - UKALL14 Consolidation [Cycle 2]"
},
{
"code" : "312521000210100",
"display" : "LEU - UKALL14 Consolidation [Cycle 1] [over 40 years]"
},
{
"code" : "312511000210105",
"display" : "LEU - UKALL14 Intensification/CNS prophylaxis [over 40 years]"
},
{
"code" : "312501000210108",
"display" : "LEU - UKALL14 - Phase 2 Induction"
},
{
"code" : "312491000210103",
"display" : "LEU - UKALL14 [over 40 years] - Phase 1 Induction"
},
{
"code" : "312481000210100",
"display" : "LEU ALL - UKALL14 [over 40 years]"
},
{
"code" : "312471000210102",
"display" : "LYM NHL B-cell - O-CHOP21 [oBINUTUZumab, CYCLOPHOSPHamide, DOXOrubicin, vinCRISTine and prEDNISone]"
},
{
"code" : "312461000210108",
"display" : "LYM - DA-R-EPOCH LEVEL 6"
},
{
"code" : "312451000210105",
"display" : "LYM - DA-R-EPOCH LEVEL 5"
},
{
"code" : "312441000210107",
"display" : "LYM - DA-R-EPOCH LEVEL 4"
},
{
"code" : "312431000210104",
"display" : "LYM - DA-R-EPOCH LEVEL 3"
},
{
"code" : "312421000210101",
"display" : "LYM - DA-R-EPOCH LEVEL 2"
},
{
"code" : "312411000210106",
"display" : "LYM - DA-R-EPOCH LEVEL minus 3"
},
{
"code" : "312401000210109",
"display" : "LYM - DA-R-EPOCH LEVEL minus 2"
},
{
"code" : "312391000210106",
"display" : "LYM - DA-R-EPOCH LEVEL minus 1"
},
{
"code" : "312381000210109",
"display" : "LYM - DA-R-EPOCH LEVEL 1"
},
{
"code" : "312371000210107",
"display" : "LYM NHL B-cell - DA-R-EPOCH [Dose-adjusted RITUximab, etoposide, prEDNIsone, vinCRISTine, CYCLOPHOSPHamide and DOXOrubicin] [9 levels]"
},
{
"code" : "312361000210101",
"display" : "LEU - HyperCVAD Part B [60 years and under] Intrathecal CNS prophylaxis High Risk"
},
{
"code" : "312351000210104",
"display" : "LEU - HyperCVAD Part B [60 years and under] Intrathecal CNS prophylaxis Unknown Risk [default]"
},
{
"code" : "312341000210102",
"display" : "LEU - HyperCVAD Part A [60 years and under] Intrathecal CNS prophylaxis High Risk"
},
{
"code" : "312331000210105",
"display" : "LEU - HyperCVAD Part A [60 years and under] Intrathecal CNS prophylaxis Unknown Risk [default]"
},
{
"code" : "312321000210108",
"display" : "LEU ALL - HyperCVAD Part A and B followed by POMP Maintenance [60 years and under]"
},
{
"code" : "312311000210103",
"display" : "LEU - HyperCVAD POMP Maintenance"
},
{
"code" : "312301000210100",
"display" : "LEU - HyperCVAD Part B [over 60 years] Intrathecal CNS prophylaxis High Risk"
},
{
"code" : "312291000210104",
"display" : "LEU - HyperCVAD Part B [over 60 years] Intrathecal CNS prophylaxis Unknown Risk [default]"
},
{
"code" : "312281000210101",
"display" : "LEU - HyperCVAD Part A [over 60 years] Intrathecal CNS prophylaxis High Risk"
},
{
"code" : "312271000210103",
"display" : "LEU - HyperCVAD Part A [over 60 years] Intrathecal CNS prophylaxis Unknown Risk [default]"
},
{
"code" : "312261000210109",
"display" : "LEU ALL - HyperCVAD Part A and B followed by POMP Maintenance [over 60 years]"
},
{
"code" : "312251000210106",
"display" : "SAR - VAC [vinCRISTine, daCTINomycin and CYCLOPHOSPHamide][Q2W]"
},
{
"code" : "312241000210108",
"display" : "SAR Ewing sarcoma - VAC, VC and IE [Q2W]"
},
{
"code" : "312231000210100",
"display" : "SAR - VAC + VV [vinCRISTine day 1, 8 and 15, daCTINomycin and CYCLOPHOSPHamide] ARST0431 [high risk]"
},
{
"code" : "312221000210102",
"display" : "SAR - VAC [vinCRISTine, daCTINomycin and CYCLOPHOSPHamide] ARST0431 [high risk]"
},
{
"code" : "312211000210107",
"display" : "SAR - VDC + V [vinCRISTine days 1 and 8, DOXOrubicin and CYCLOPHOSPHamide] [Q3W] ARST0431 [high risk]"
},
{
"code" : "312201000210105",
"display" : "SAR - IE [IFOSFamide and etoposide] [Q3W] ARST0431 [high risk]"
},
{
"code" : "312191000210108",
"display" : "SAR - IE [IFOSFamide and etoposide] [Q2W] ARST0431 [high risk]"
},
{
"code" : "312181000210106",
"display" : "SAR - VDC + V [vinCRISTine days 1 and 8, DOXOrubicin and CYCLOPHOSPHamide] [Q2W] ARST0431 [high risk]"
},
{
"code" : "312171000210109",
"display" : "SAR - vinCRISTine days 1 and 8 and irinotecan ARST0431 [high risk]"
},
{
"code" : "312161000210103",
"display" : "SAR - vinCRISTine days 1, 8 and 15 and irinotecan ARST0431 [high risk]"
},
{
"code" : "312151000210101",
"display" : "SAR Rhabdomyosarcoma - vinCRISTine, irinotecan, IFOSFamide, etoposide, DOXOrubicin, CYCLOPHOSPHamide and daCTINomycin [ARST0431] [high risk]"
},
{
"code" : "312141000210104",
"display" : "SAR - VAC [vinCRISTine, daCTINomycin and CYCLOPHOSPHamide][Q3W]"
},
{
"code" : "312131000210107",
"display" : "SAR Ewing sarcoma - VAC, VC and IE [Q3W]"
},
{
"code" : "312121000210105",
"display" : "SAR - VC [vinCRISTine and CYCLOPHOSPHamide][Q3W]"
},
{
"code" : "312111000210100",
"display" : "SAR - IE [IFOSfamide and etoposide][Q3W]"
},
{
"code" : "312101000210102",
"display" : "SAR - VDC [vinCRISTine, DOXOrubicin and CYCLOPHOSPHamide] [Q3W]"
},
{
"code" : "312091000210109",
"display" : "SAR Ewing sarcoma - VDC, VC and IE [Q3W]"
},
{
"code" : "312081000210107",
"display" : "SAR - MA [metHOTREXATe and DOXOrubicin]"
},
{
"code" : "312071000210105",
"display" : "SAR - MAP [metHOTREXATe, DOXOrubicin and cISplatin]"
},
{
"code" : "312061000210104",
"display" : "SAR Osteosarcoma - MAP [metHOTREXATe, DOXOrubicin and cISplatin]"
},
{
"code" : "312051000210102",
"display" : "PCN MM - pamidronate 90mg Q4W"
},
{
"code" : "312041000210100",
"display" : "LEU ALL precursor B-cell - blinatumomab [CNS1 and CNS2]"
},
{
"code" : "312031000210108",
"display" : "LEU ALL precursor B-cell - blinatumomab [CNS3]"
},
{
"code" : "312021000210106",
"display" : "CRC REC Locally advanced - dostarlimab"
},
{
"code" : "312011000210101",
"display" : "CRC - mFOLFOX6 [low dose foliNIc acid] 9 cycles"
},
{
"code" : "312001000210103",
"display" : "CRC - mFOLFOX6 [high dose foliNIc acid] 9 cycles"
},
{
"code" : "311991000210101",
"display" : "CRC - CAPOX 6 cycles"
},
{
"code" : "311981000210103",
"display" : "CRC REC Neoadjuvant - RAPIDO Total Neoadjuvant Therapy"
},
{
"code" : "311971000210100",
"display" : "CRC Metastatic - irinotecan [Q3W] dose reduced"
},
{
"code" : "311961000210106",
"display" : "CRC Metastatic - CETUximab Q2W"
},
{
"code" : "311951000210108",
"display" : "CRC Metastatic - trifluridine/tipiracil and beVACizumab"
},
{
"code" : "311941000210105",
"display" : "CRC Metastatic - trifluridine/tipiracil"
},
{
"code" : "311931000210102",
"display" : "CRC Metastatic - pembrolizumab Q6W [flat dosing]"
},
{
"code" : "311921000210104",
"display" : "CRC Locally advanced - ipilimumab and nivolumab"
},
{
"code" : "311911000210109",
"display" : "CRC Metastatic - pembrolizumab Q3W [flat dosing]"
},
{
"code" : "311901000210107",
"display" : "CRC Metastatic - CETUximab [Q2W] and encorafenib"
},
{
"code" : "311891000210106",
"display" : "CRC Metastatic - CETUximab [Q2W] and daBRAFEnib"
},
{
"code" : "311881000210109",
"display" : "LEU - AIDA consolidation 3 [70 years and under]"
},
{
"code" : "311871000210107",
"display" : "LEU - AIDA consolidation 2 [70 years and under]"
},
{
"code" : "311861000210101",
"display" : "LEU - AIDA consolidation 1 [70 years and under]"
},
{
"code" : "311851000210104",
"display" : "LEU - AIDA induction [70 years and under]"
},
{
"code" : "311841000210102",
"display" : "LEU APL - AIDA induction and consolidations 1, 2 and 3 [70 years and under]"
},
{
"code" : "311831000210105",
"display" : "LEU - arsenic trioxide and tretinoin consolidation [AML17]"
},
{
"code" : "311821000210108",
"display" : "LEU - arsenic trioxide and tretinoin induction [AML17]"
},
{
"code" : "311811000210103",
"display" : "LEU APL - arsenic trioxide and tretinoin induction followed by consolidation [AML17]"
},
{
"code" : "311801000210100",
"display" : "LEU - APML4 maintenance [61 to 70 years]"
},
{
"code" : "311791000210104",
"display" : "LEU - APML4 consolidation 2 [61 to 70 years]"
},
{
"code" : "311781000210101",
"display" : "LEU - APML4 consolidation 1 [61 to 70 years]"
},
{
"code" : "311771000210103",
"display" : "LEU - APML4 induction [61 to 70 years]"
},
{
"code" : "311761000210109",
"display" : "LEU APL - APML4 induction, consolidation 1 and 2 followed by maintenance [61 to 70 years]"
},
{
"code" : "311751000210106",
"display" : "LEU - APML4 maintenance [over 70 years]"
},
{
"code" : "311741000210108",
"display" : "LEU - APML4 consolidation 2 [over 70 years]"
},
{
"code" : "311721000210102",
"display" : "LEU - APML4 consolidation 1 [over 70 years]"
},
{
"code" : "311711000210107",
"display" : "LEU - APML4 induction [over 70 years]"
},
{
"code" : "311701000210105",
"display" : "LEU APL - APML4 induction, consolidation 1 and 2 followed by maintenance [over 70 years]"
},
{
"code" : "311691000210105",
"display" : "LEU - Pethema LPA2005 maintenance [70 years and under] [intermediate risk]"
},
{
"code" : "311681000210108",
"display" : "LEU - Pethema LPA2005 consolidation 3 [70 years and under] [intermediate risk]"
},
{
"code" : "311671000210106",
"display" : "LEU - Pethema LPA2005 consolidation 2 [70 years and under] [intermediate risk]"
},
{
"code" : "311661000210100",
"display" : "LEU - Pethema LPA2005 consolidation 1 [70 years and under] [intermediate risk]"
},
{
"code" : "311651000210103",
"display" : "LEU - Pethema LPA2005 induction [70 years and under] [intermediate risk]"
},
{
"code" : "311641000210101",
"display" : "LEU APL - Pethema LPA2005 induction and consolidations 1, 2 and 3 followed by maintenance [70 years and under] [intermediate risk]"
},
{
"code" : "311631000210109",
"display" : "LEU HCL - cladribine and RITUximab"
},
{
"code" : "311621000210107",
"display" : "LEU - arsenic trioxide and tretinoin consolidation [standard risk]"
},
{
"code" : "311611000210102",
"display" : "LEU - arsenic trioxide, tretinoin and prEDNISone induction [standard risk]"
},
{
"code" : "311601000210104",
"display" : "LEU APL - arsenic trioxide, tretinoin and prEDNISone induction followed by consolidation [standard risk]"
},
{
"code" : "311591000210109",
"display" : "LEU - APML4 maintenance [60 years and under]"
},
{
"code" : "311581000210107",
"display" : "LEU - APML4 consolidation 2 [60 years and under]"
},
{
"code" : "311571000210105",
"display" : "LEU - APML4 consolidation 1 [60 years and under]"
},
{
"code" : "311561000210104",
"display" : "LEU - APML4 induction [60 years and under]"
},
{
"code" : "311551000210102",
"display" : "LEU APL - APML4 induction, consolidation 1 and 2 followed by maintenance [60 years and under]"
},
{
"code" : "311541000210100",
"display" : "LEU - UKALL14 with daSATinib Maintenance"
},
{
"code" : "311531000210108",
"display" : "LEU - UKALL14 with daSATinib Consolidation [Cycle 4]"
},
{
"code" : "311521000210106",
"display" : "LEU - UKALL14 with daSATinib consolidation/delayed intensification [Cycle 3]"
},
{
"code" : "311511000210101",
"display" : "LEU - UKALL14 with daSATinib Consolidation [Cycle 1 and 2]"
},
{
"code" : "311501000210103",
"display" : "LEU - UKALL14 with daSATinib Intensification/CNS prophylaxis"
},
{
"code" : "311491000210108",
"display" : "LEU - UKALL14 with daSATinib Phase 2 Induction"
},
{
"code" : "311481000210106",
"display" : "LEU - UKALL14 with daSATinib Phase 1 Induction"
},
{
"code" : "311471000210109",
"display" : "LEU ALL precursor B-cell BCR-ABL1+ - UKALL14 with daSATinib"
},
{
"code" : "311461000210103",
"display" : "LEU - UKALL14 with RITUximab and daSATinib [not for transplant] Maintenance"
},
{
"code" : "311451000210101",
"display" : "LEU - UKALL14 with RITUximab and daSATinib [not for transplant] Consolidation/delayed intensification [Cycle 3]"
},
{
"code" : "311441000210104",
"display" : "LEU - UKALL14 with RITUximab and daSATinib [not for transplant] Intensification/CNS prophylaxis"
},
{
"code" : "311431000210107",
"display" : "LEU - UKALL14 with RITUximab and daSATinib [not for transplant] Phase 2 Induction"
},
{
"code" : "311421000210105",
"display" : "LEU ALL precursor B-cell BCR-ABL1+ - UKALL14 with RITUximab and daSATinib [not for transplant]"
},
{
"code" : "311411000210100",
"display" : "LYM - High dose cytarabine [2000mg/m2 TWICE daily days 1 and 2] Consolidation"
},
{
"code" : "311401000210102",
"display" : "LYM - R-MPV alternating with R-MV"
},
{
"code" : "311391000210100",
"display" : "LYM NHL B-cell PCNSL - R-MPV [RITUximab, metHOTREXATe, procarbazine and vinCRISTine] followed by high dose cytarabine"
},
{
"code" : "311381000210102",
"display" : "LYM - EA [etoposide and cytarabine]"
},
{
"code" : "311371000210104",
"display" : "LYM - MT-R"
},
{
"code" : "311361000210105",
"display" : "LYM NHL B-cell PCNSL - MT-R [metHOTREXate, temozolomide and RITUximab] followed by EA [etoposide and cytarabine]"
},
{
"code" : "311351000210107",
"display" : "LYM NHL B-cell Primary Testicular - high dose metHOTREXATe [CNS prophylaxis]"
},
{
"code" : "311341000210109",
"display" : "LYM NHL B-cell PCNSL - MATRix [metHOTREXATe, cytarabine, thiotepa and RITUximab] Induction"
},
{
"code" : "311331000210101",
"display" : "LEU CLL Relapsed - aLEMTUzumab [subcut]"
},
{
"code" : "311321000210103",
"display" : "LEU CLL - venetoclax and oBINUTUZumab"
},
{
"code" : "311311000210108",
"display" : "LEU CLL - RITUximab and bendamustine"
},
{
"code" : "311301000210106",
"display" : "LEU CLL Relapsed - aLEMTUzumab [IV]"
},
{
"code" : "311291000210107",
"display" : "LEU - UKALL14 with RITUximab and daSATinib Consolidation [Cycle 4]"
},
{
"code" : "311281000210105",
"display" : "LEU - UKALL14 with RITUximab and daSATinib consolidation/delayed intensification [Cycle 3] [for transplant]"
},
{
"code" : "311271000210108",
"display" : "LEU - UKALL14 with RITUximab and daSATinib Consolidation [Cycle 1 and 2]"
},
{
"code" : "311261000210102",
"display" : "LEU - UKALL14 with RITUximab and daSATinib [for transplant] Intensification/CNS prophylaxis"
},
{
"code" : "311251000210100",
"display" : "LEU - UKALL14 with RITUximab and daSATinib Phase 2 Induction [for transplant]"
},
{
"code" : "311241000210103",
"display" : "LEU - UKALL14 with RITUximab and daSATinib Phase 1 Induction"
},
{
"code" : "311231000210106",
"display" : "LEU - dexamethasone 6 mg/m2 days 1 to 5"
},
{
"code" : "311221000210109",
"display" : "LEU ALL precursor B-cell BCR-ABL1+ - UKALL14 with RITUximab and daSATinib [for transplant]"
},
{
"code" : "311211000210104",
"display" : "LYM - oBINUTUZumab maintenance"
},
{
"code" : "311201000210101",
"display" : "LYM - bendamustine and oBINUTUZumab"
},
{
"code" : "311191000210103",
"display" : "LYM NHL B-cell - bendamustine and oBINUTUZumab"
},
{
"code" : "311181000210100",
"display" : "LYM NHL NK/T-cell Extra Nodal - DDGP [dexamethasone, cISplatin, gemcitabine and pegaspargase]"
},
{
"code" : "311171000210102",
"display" : "LEU CLL - venetoclax and RITUximab"
},
{
"code" : "311161000210108",
"display" : "LEU - imatinib 600"
},
{
"code" : "311151000210105",
"display" : "LEU - imatinib 400"
},
{
"code" : "311141000210107",
"display" : "LEU CML - imatinib"
},
{
"code" : "311131000210104",
"display" : "LYM NHL B-cell - Flyer R-CHOP21 [RITUximab, CYCLOPHOSPHamide, DOXOrubicin, vinCRISTine and prEDNISone] followed by RITUximab"
},
{
"code" : "311121000210101",
"display" : "LEU - UKALL60+ Maintenance"
},
{
"code" : "311111000210106",
"display" : "LEU - UKALL60+ Consolidation"
},
{
"code" : "311101000210109",
"display" : "LEU - UKALL60+ Phase 2 Induction"
},
{
"code" : "311091000210102",
"display" : "LEU - UKALL60+ Phase 1 Induction"
},
{
"code" : "311081000210104",
"display" : "LEU ALL - UKALL60+ [non-intensive]"
},
{
"code" : "311071000210101",
"display" : "LEU - UKALL60+ with daSATinib Maintenance"
},
{
"code" : "311061000210107",
"display" : "LEU - UKALL60+ with daSATinib Consolidation"
},
{
"code" : "311051000210109",
"display" : "LEU - UKALL60+ with daSATinib Phase 2 Induction"
},
{
"code" : "311041000210106",
"display" : "LEU - UKALL60+ with daSATinib Phase 1 Induction"
},
{
"code" : "311031000210103",
"display" : "LEU ALL BCR-ABL1+ - UKALL60+ with daSATinib"
},
{
"code" : "311021000210100",
"display" : "LEU - UKALL60+ with imatinib Maintenance"
},
{
"code" : "311011000210105",
"display" : "LEU - UKALL60+ with imatinib Consolidation"
},
{
"code" : "311001000210108",
"display" : "LEU - UKALL60+ with imatinib Phase 2 Induction"
},
{
"code" : "310991000210109",
"display" : "LEU - UKALL60+ with imatinib Phase 1 Induction"
},
{
"code" : "310981000210107",
"display" : "LEU - dexamethasone 6 mg/m2 [max 10 mg] days 1 to 5"
},
{
"code" : "310971000210105",
"display" : "LEU ALL BCR-ABL1+ - UKALL60+ with imatinib"
},
{
"code" : "310961000210104",
"display" : "LEU AML - DA+GO-2 [DAUNOrubicin, cytarabine and Mylotarg [gemtuzumab ozogamicin]] induction [de novo CD33+] [good or intermediate risk]"
},
{
"code" : "310951000210102",
"display" : "LEU AML - 7 + 3 IDA [IDArubicin and cytarabine] induction"
},
{
"code" : "310941000210100",
"display" : "LEU - High dose cytarabine [1000mg/m2 TWICE daily days 1 to 6] consolidation"
},
{
"code" : "310931000210108",
"display" : "LEU - DA[45] 3+7 [DAUNOrubicin and cytarabine] induction [over 60 years]"
},
{
"code" : "303631000210108",
"display" : "LEU AML - DA[45] 3+7 [DAUNOrubicin and cytarabine] induction followed by high dose cytarabine consolidation [over 60 years]"
},
{
"code" : "303621000210106",
"display" : "LEU - High dose cytarabine and midostaurin consolidation [under 60 years]"
},
{
"code" : "303611000210101",
"display" : "LEU - DAUNOrubicin, cytarabine and midostaurin induction [under 60 years]"
},
{
"code" : "303601000210103",
"display" : "LEU AML - DAUNOrubicin, cytarabine and midostaurin induction, high dose cytarabine and midostaurin consolidation followed by midostaurin maintenance [FLT3 mutated] [under 60 years]"
},
{
"code" : "303591000210108",
"display" : "LEU - Midostaurin maintenance"
},
{
"code" : "303581000210106",
"display" : "LEU - High dose cytarabine and midostaurin consolidation [60 years and over]"
},
{
"code" : "303571000210109",
"display" : "LEU - DAUNOrubicin, cytarabine and midostaurin induction [60 years and over]"
},
{
"code" : "303561000210103",
"display" : "LEU AML - DAUNOrubicin, cytarabine and midostaurin induction, high dose cytarabine and midostaurin consolidation followed by midostaurin maintenance [FLT3 mutated] [60 years and over]"
},
{
"code" : "303551000210101",
"display" : "LEU - Manchester Protocol [mitoxantrone and cytarabine IV] consolidation"
},
{
"code" : "303541000210104",
"display" : "LEU - Manchester Protocol [mitoxantrone and cytarabine IV] induction"
},
{
"code" : "303531000210107",
"display" : "LEU AML - Manchester Protocol [mitoxantrone and cytarabine IV] induction followed by consolidation"
},
{
"code" : "303521000210105",
"display" : "LYM NHL B-cell PCNSL Relapsed - R-IE [RITUximab, IFOSFamide and etoposide]"
},
{
"code" : "303511000210100",
"display" : "LYM - procarbazine [100 mg daily for 5 days]"
},
{
"code" : "303501000210102",
"display" : "LYM - R-MP [RITUximab, metHOTREXATe, procarbazine] [65 years and over]"
},
{
"code" : "303491000210107",
"display" : "LYM NHL B-cell PCNSL - R-MP [RITUximab, metHOTREXATe and procarbazine] followed by procarbazine maintenance [65 years and over]"
},
{
"code" : "303481000210105",
"display" : "LYM NHL B-cell - RITUximab and bendamustine"
},
{
"code" : "303471000210108",
"display" : "LYM NHL B-cell - RITUximab Maintenance Q8W"
},
{
"code" : "303461000210102",
"display" : "LYM NHL B-cell - RITUximab Q1W"
},
{
"code" : "303451000210100",
"display" : "GYN CX Advanced - cISplatin, PACLItaxel, beVACizumab and pembrolizumab"
},
{
"code" : "303441000210103",
"display" : "GYN CX Advanced - cISplatin, PACLItaxel and pembrolizumab"
},
{
"code" : "265711000210103",
"display" : "Neuroendocrine carcinoma - cISplatin and etoposide 60/120 chemoradiation"
},
{
"code" : "265701000210100",
"display" : "Neuroendocrine carcinoma - cISplatin and etoposide 80/100 chemoradiation"
},
{
"code" : "265691000210100",
"display" : "Desmoid fibromatosis - metHOTREXATe and vinBLASTine"
},
{
"code" : "265681000210102",
"display" : "SAR STS Metastatic - DOCEtaxel and gemcitabine 900"
},
{
"code" : "265671000210104",
"display" : "SAR STS Metastatic - DOCEtaxel and gemcitabine 675 [GeDDis]"
},
{
"code" : "265661000210105",
"display" : "SAR STS Advanced - trabectedin"
},
{
"code" : "265651000210107",
"display" : "SAR STS Advanced - pAZOPanib"
},
{
"code" : "265641000210109",
"display" : "SAR STS Advanced - IFOSFamide [3-day]"
},
{
"code" : "265631000210101",
"display" : "SAR - VC [vinCRISTine and CYCLOPHOSPHamide][Q2W]"
},
{
"code" : "265621000210103",
"display" : "SAR - IE [IFOSfamide and etoposide][Q2W]"
},
{
"code" : "265611000210108",
"display" : "SAR - VDC [vinCRISTine, DOXOrubicin and CYCLOPHOSPHamide] with dexrazoxane [Q2W]"
},
{
"code" : "265601000210106",
"display" : "SAR Ewing sarcoma - VDC with dexrazoxane, VC and IE [Q2W]"
},
{
"code" : "265591000210101",
"display" : "SAR STS Advanced - DOXOrubicin and IFOSFamide 25/3000"
},
{
"code" : "265581000210103",
"display" : "SAR STS Advanced - DOXOrubicin and IFOSFamide 20/2000"
},
{
"code" : "265571000210100",
"display" : "SAR Osteosarcoma Advanced - DOXOrubicin [1-day dosing] and cISplatin"
},
{
"code" : "265561000210106",
"display" : "SAR Ewing sarcoma Relapsed - CYCLOPHOSPHamide and topotecan"
},
{
"code" : "265551000210108",
"display" : "SAR Rhabdomyosarcoma Relapsed - VIT [vinCRISTine, irinotecan and temozolomide]"
},
{
"code" : "265541000210105",
"display" : "SAR Osteosarcoma Advanced - DOXOrubicin [3-day split dosing] and cISplatin"
},
{
"code" : "265531000210102",
"display" : "LYM NHL B-cell - R-MiniCHOP [RITUximab, CYCLOPHOSPHamide, DOXOrubicin, vinCRISTine and prEDNISone]"
},
{
"code" : "265521000210104",
"display" : "Neuroendocrine carcinoma Advanced - cARBOplatin and oral etoposide"
},
{
"code" : "265411000210105",
"display" : "GU Renal cell Metastatic - aXITinib and avelumab [flat dose]"
},
{
"code" : "265401000210108",
"display" : "GU - nivolumab maintenance Q2W [flat dosing]"
},
{
"code" : "265391000210105",
"display" : "GU Renal cell Advanced - nivolumab and ipilimumab induction followed by nivolumab maintenance Q2W [flat dosing]"
},
{
"code" : "265381000210108",
"display" : "GU - nivolumab maintenance Q4W [flat dosing]"
},
{
"code" : "265371000210106",
"display" : "GU - nivolumab and ipilimumab induction"
},
{
"code" : "265361000210100",
"display" : "GU Renal cell Advanced - nivolumab and ipilimumab induction followed by nivolumab maintenance Q4W [flat dosing]"
},
{
"code" : "265351000210103",
"display" : "GU URO Metastatic - PACLItaxel Q1W and pembrolizumab Q3W [flat dosing]"
},
{
"code" : "265341000210101",
"display" : "GU Renal cell Metastatic - leNVAtinib and everolimus"
},
{
"code" : "265331000210109",
"display" : "GU Bladder Urothelial - gemcitabine [low dose] chemoradiation"
},
{
"code" : "265321000210107",
"display" : "GU Bladder Urothelial Neoadjuvant - ddMVAC [metHOTREXATe, DOXOrubicin, vinBLASTine and cISplatin] dose dense"
},
{
"code" : "264811000210106",
"display" : "LEU - daSATinib 140"
},
{
"code" : "264801000210109",
"display" : "LEU - daSATinib 100"
},
{
"code" : "264791000210105",
"display" : "LEU CML - daSATinib"
},
{
"code" : "264781000210108",
"display" : "LEU HCL - cladribine"
},
{
"code" : "264771000210106",
"display" : "PCN MM - lenalidomide and dexamethasone"
},
{
"code" : "264761000210100",
"display" : "GYN VUL Advanced - ciSplatin [Q1W] chemoradiation"
},
{
"code" : "264751000210103",
"display" : "LUNG NSCLC Locally advanced/Metastatic - cARBOplatin and gemcitabine"
},
{
"code" : "264741000210101",
"display" : "LUNG NSCLC Locally advanced/Metastatic - cARBOplatin and vinORELBine"
},
{
"code" : "264731000210109",
"display" : "SAR Ewing sarcoma Relapsed - irinotecan and temozolomide"
},
{
"code" : "264721000210107",
"display" : "Desmoid fibromatosis - metHOTREXATe and vinORELBine"
},
{
"code" : "264411000210109",
"display" : "LEU CLL - chlorambucil and oBINUTUZumab"
},
{
"code" : "264401000210107",
"display" : "LEU - nilotinib 300"
},
{
"code" : "264391000210109",
"display" : "LEU - nilotinib 400"
},
{
"code" : "264381000210107",
"display" : "LEU CML - nilotinib"
},
{
"code" : "264371000210105",
"display" : "CNS GBM Recurrent - beVACizumab and irinotecan 340 mg/m2"
},
{
"code" : "264361000210104",
"display" : "LYM Relapsed - ICE [fractionated IFOSFamide, cARBOplatin and etoposide]"
},
{
"code" : "264351000210102",
"display" : "LYM NHL B-cell Relapsed - R-ICE [RITUximab, fractionated IFOSFamide, cARBOplatin and etoposide]"
},
{
"code" : "264341000210100",
"display" : "LYM NHL B-cell MCL - R-BAC [RITUximab, bendamustine and cytarabine]"
},
{
"code" : "264331000210108",
"display" : "LYM NHL B-cell Lymphoplasmacytic - ibrutinib [Waldenström macroglobulinema]"
},
{
"code" : "264321000210106",
"display" : "LYM HL Advanced - ChlVPP [chlorambucil, vinBLASTine, procarbazine and prEDNISone]"
},
{
"code" : "264011000210104",
"display" : "PCN MM Relapsed - pomalidomide, bortezomib and dexamethasone"
},
{
"code" : "264001000210101",
"display" : "Myelodysplastic syndrome - azacitidine [7 day]"
},
{
"code" : "263991000210105",
"display" : "Myelodysplastic syndrome - azacitidine [5 day]"
},
{
"code" : "263981000210108",
"display" : "LEU AML Relapsed - FLAG [fludarabine, cytarabine and filgrastim] [60 years and over]"
},
{
"code" : "263971000210106",
"display" : "CNS GBM Recurrent - beVACizumab and lomustine"
},
{
"code" : "263961000210100",
"display" : "CNS GBM Recurrent - beVACizumab Q2W"
},
{
"code" : "263951000210103",
"display" : "CNS GBM Recurrent - beVACizumab Q3W"
},
{
"code" : "263941000210101",
"display" : "CNS GLI Recurrent - temozolomide [high grade]"
},
{
"code" : "263931000210109",
"display" : "CNS - temozolomide following chemoradiation"
},
{
"code" : "263921000210107",
"display" : "CNS - temozolomide chemoradiation"
},
{
"code" : "60091000210105",
"display" : "GYN - cARBOplatin and PACLItaxel [following chemoradiation]"
},
{
"code" : "60081000210108",
"display" : "GYN - cISplatin chemoradiation"
},
{
"code" : "60071000210106",
"display" : "GYN END Adjuvant - cISplatin chemoradiation followed by cARBOplatin and PACLItaxel"
},
{
"code" : "60061000210100",
"display" : "GYN OV Recurrent - topotecan"
},
{
"code" : "60051000210103",
"display" : "GYN END Adjuvant - cARBOplatin and PACLItaxel [chemotherapy-only]"
},
{
"code" : "60041000210101",
"display" : "GYN VUL Advanced - CARBOplatin [Q1W] chemoradiation"
},
{
"code" : "60031000210109",
"display" : "GYN OV Recurrent - topotecan and beVACizumab Q4W"
},
{
"code" : "60021000210107",
"display" : "GYN GTD - TP-TE [PACLItaxel, cISplatin - PACLItaxel and etoposide] [relapsed or high risk]"
},
{
"code" : "60011000210102",
"display" : "GYN GTD - EP-EMA [etoposide, ciSplatin, etoposide, metHOTREXATe and daCTINomycin] [high risk]"
},
{
"code" : "60001000210104",
"display" : "GYN OV Low grade serous carcinoma - letrozole maintenance"
},
{
"code" : "59991000210107",
"display" : "GYN OV Recurrent - CYCLOPHOSPHamide oral [2/4 dosing]"
},
{
"code" : "59981000210105",
"display" : "GYN OV Recurrent - CYCLOPHOSPHamide oral [continuous]"
},
{
"code" : "59971000210108",
"display" : "GYN OV Recurrent - etoposide oral"
},
{
"code" : "59961000210102",
"display" : "GYN OV Recurrent - gemcitabine"
},
{
"code" : "59951000210100",
"display" : "GYN OV Recurrent - pegylated liposomal DOXOrubicin hydrochloride"
},
{
"code" : "59941000210103",
"display" : "GYN OV Recurrent - pegylated liposomal DOXOrubicin hydrochloride and beVACizumab"
},
{
"code" : "59931000210106",
"display" : "GYN CX Locally advanced - cARBOplatin [Q1W] chemoradiation"
},
{
"code" : "59921000210109",
"display" : "GYN CX Locally advanced - cISplatin [Q1W] chemoradiation"
},
{
"code" : "59911000210104",
"display" : "GYN GTD - EMA-CO [etoposide, metHOTREXATe, daCTINomycin, CYCLOPHOSPHamide and vinCRISTine] [high risk]"
},
{
"code" : "59901000210101",
"display" : "LUNG NSCLC Locally advanced - durvalumab Q2W [weight based dosing]"
},
{
"code" : "496201000210103",
"display" : "Malignancy, direct spread to cervix and/or vagina"
},
{
"code" : "496211000210101",
"display" : "Cervix specimen from partial hysterectomy"
},
{
"code" : "496231000210108",
"display" : "Cervix specimen from total hysterectomy"
},
{
"code" : "496241000210100",
"display" : "Polyp specimen"
},
{
"code" : "496191000210100",
"display" : "Endocervical adenocarcinoma, superficially invasive"
},
{
"code" : "497441000210104",
"display" : "SACT regimen type"
},
{
"code" : "497451000210101",
"display" : "Prescribed dose unit"
},
{
"code" : "497461000210103",
"display" : "Administered dose unit"
},
{
"code" : "495991000210106",
"display" : "Tumour width"
},
{
"code" : "496001000210105",
"display" : "Tumour depth"
},
{
"code" : "495981000210109",
"display" : "Tumour length"
},
{
"code" : "7283002",
"display" : "Base of tongue"
},
{
"code" : "1340143004",
"display" : "Intrahepatic bile duct"
},
{
"code" : "505941000210108",
"display" : "Extra-adrenal paraganglioma primary"
},
{
"code" : "507401000210108",
"display" : "Histopathology request"
},
{
"code" : "507411000210105",
"display" : "Histopathology report"
}
],
"text" : {
}
}
XIG built as of ??metadata-date??. Found ??metadata-resources?? resources in ??metadata-packages?? packages.